Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
ddp modified	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer
creator	label
publisher	pref label
tabling member	label

Search

105962

	human indexable
	published
	registered interest
	answer date	05/11/2014
	date	03/11/2014
	date tabled	03/11/2014
	ddp created	03/11/2014 23:36:36
	ddp modified	08/02/2015 06:10:19
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	IVF
	house id	1
	identifier	212894
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	10/11/2014 17:39:40
	question text	To ask the Secretary of State for Health, what steps he is taking to reduce variation in the price of IVF cycles between clinical commissioning groups.
	session	2014/15
	session number	4
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	title	House of Commons Tabled Parliamentary Question 2014/15 212894
	type	WrittenParliamentaryQuestion
	uin	212894
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4079 label Biography information for Julian Sturdy
	publisher	25259 pref label House of Commons
	tabling member	4079 label Biography information for Julian Sturdy

142239

	human indexable
	published
	registered interest
	answer date	10/11/2014
	date	06/11/2014
	date tabled	06/11/2014
	ddp created	06/11/2014 20:15:15
	ddp modified	08/02/2015 07:32:17
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Care Homes: Fees and Charges
	house id	1
	identifier	213681
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	18/11/2014 15:42:59
	question text	To ask the Secretary of State for Health, what assessment he has made of the effect of his Department’s guidance on charging for residential accommodation on the financial independence of adults in residential care.
	session	2014/15
	session number	4
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	title	House of Commons Tabled Parliamentary Question 2014/15 213681
	type	WrittenParliamentaryQuestion
	uin	213681
	version	2
	written parliamentary question type	Ordinary
	answer	answer
	creator	4079 label Biography information for Julian Sturdy
	publisher	25259 pref label House of Commons
	tabling member	4079 label Biography information for Julian Sturdy

114567

	human indexable
	published
	registered interest
	answer date	07/11/2014
	date	05/11/2014
	date tabled	05/11/2014
	ddp created	05/11/2014 23:10:42
	ddp modified	08/02/2015 06:59:41
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Abortion
	house id	1
	identifier	213561
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	17/11/2014 16:49:21
	question text	To ask the Secretary of State for Health, if he will take steps to clarify the law on abortion for the purpose of gender selection; and if he will make a statement.
	session	2014/15
	session number	4
	tabling member constituency	Wycombe
	tabling member printed	Steve Baker
	title	House of Commons Tabled Parliamentary Question 2014/15 213561
	type	WrittenParliamentaryQuestion
	uin	213561
	version	2
	written parliamentary question type	Ordinary
	answer	answer attachment 1 title Abortion Guidance May 2014
	creator	4064 label Biography information for Mr Steve Baker
	publisher	25259 pref label House of Commons
	tabling member	4064 label Biography information for Mr Steve Baker

142228

	human indexable
	published
	registered interest
	answer date	10/11/2014
	date	06/11/2014
	date tabled	06/11/2014
	ddp created	06/11/2014 20:14:57
	ddp modified	08/02/2015 07:31:33
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services and Social Services
	house id	1
	identifier	213739
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	18/11/2014 15:12:26
	question text	To ask the Secretary of State for Health, what assessment he has made of the recent report by Healthwatch England entitled, Suffering in Silence, published in October 2014; and if he will make a statement.
	session	2014/15
	session number	4
	tabling member constituency	Wycombe
	tabling member printed	Steve Baker
	title	House of Commons Tabled Parliamentary Question 2014/15 213739
	type	WrittenParliamentaryQuestion
	uin	213739
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4064 label Biography information for Mr Steve Baker
	publisher	25259 pref label House of Commons
	tabling member	4064 label Biography information for Mr Steve Baker

142222

	human indexable
	published
	registered interest
	answer date	10/11/2014
	date	06/11/2014
	date tabled	06/11/2014
	ddp created	06/11/2014 20:14:50
	ddp modified	08/02/2015 07:31:09
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Patients: Safety
	house id	1
	identifier	213774
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	18/11/2014 15:40:10
	question text	To ask the Secretary of State for Health, what recent assessment he has made of the uptake of the Sign up to Safety campaign in each (a) region and (b) clinical commissioning group area.
	session	2014/15
	session number	4
	tabling member constituency	Wolverhampton South West
	tabling member printed	Paul Uppal
	title	House of Commons Tabled Parliamentary Question 2014/15 213774
	type	WrittenParliamentaryQuestion
	uin	213774
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4078 label Biography information for Paul Uppal
	publisher	25259 pref label House of Commons
	tabling member	4078 label Biography information for Paul Uppal

143398

	human indexable
	published
	registered interest
	answer date	17/11/2014
	date	07/11/2014
	date tabled	07/11/2014
	ddp created	07/11/2014 18:11:49
	ddp modified	08/02/2015 07:44:11
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Drugs
	house id	1
	identifier	213834
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	17/11/2014 11:14:36
	question text	To ask the Secretary of State for Health, if he will issue a direction under Regulation 7 of the National Institue for Health and Care Excellence (NICE) (Constitution and Functions) and the Health and Social Care Information Centre (Functions) Regulations 2013 to exempt clinical commissioning groups from the requirement to comply with NICE Technology Assessment Guidance TA155, in order that NHS commissioners can make their own decision on whether to issue the drug Avastin and Lucentis.
	session	2014/15
	session number	4
	tabling member constituency	West Bromwich East
	tabling member printed	Mr Tom Watson
	title	House of Commons Tabled Parliamentary Question 2014/15 213834
	type	WrittenParliamentaryQuestion
	uin	213834
	version	1
	written parliamentary question type	NamedDay
	answer	answer
	creator	1463 label Biography information for Lord Watson of Wyre Forest
	publisher	25259 pref label House of Commons
	tabling member	1463 label Biography information for Lord Watson of Wyre Forest

106317

	human indexable
	published
	registered interest
	answer date	07/11/2014
	date	04/11/2014
	date tabled	04/11/2014
	ddp created	04/11/2014 22:20:29
	ddp modified	08/02/2015 06:43:00
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer Drugs Fund
	house id	1
	identifier	213358
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	07/11/2014 14:49:39
	question text	To ask the Secretary of State for Health, with reference to NHS England's consultation document Proposal for a sustainable Cancer Drug Fund, page 9, Points 24 and 25, what NHS England's overspend of the Cancer Drug Fund (CDF) was during its first year in charge of the CDF; whether the CDF was in budget each year prior to 1 April 2013; how much was taken from the radiotherapy budget to underwrite the overspend; from which disease area money was taken to underwrite the CDF overspend; and how much funding was taken in such a fashion to underwrite the overspend.
	session	2014/15
	session number	4
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	title	House of Commons Tabled Parliamentary Question 2014/15 213358
	type	WrittenParliamentaryQuestion
	uin	213358
	version	1
	written parliamentary question type	NamedDay
	answer	answer
	creator	4089 label Biography information for Tessa Munt
	publisher	25259 pref label House of Commons
	tabling member	4089 label Biography information for Tessa Munt

106319

	human indexable
	published
	registered interest
	answer date	07/11/2014
	date	04/11/2014
	date tabled	04/11/2014
	ddp created	04/11/2014 22:20:34
	ddp modified	08/02/2015 06:43:15
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiotherapy
	house id	1
	identifier	213359
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	07/11/2014 13:57:03
	question text	To ask the Secretary of State for Health, whether NHS England's Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review published in November 2014 is solely for the purpose of assessing the needs of intracranial radiotherapy treatment in England.
	session	2014/15
	session number	4
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	title	House of Commons Tabled Parliamentary Question 2014/15 213359
	type	WrittenParliamentaryQuestion
	uin	213359
	version	1
	written parliamentary question type	NamedDay
	answer	answer
	creator	4089 label Biography information for Tessa Munt
	publisher	25259 pref label House of Commons
	tabling member	4089 label Biography information for Tessa Munt

106320

	human indexable
	published
	registered interest
	answer date	07/11/2014
	date	04/11/2014
	date tabled	04/11/2014
	ddp created	04/11/2014 22:20:36
	ddp modified	08/02/2015 06:43:21
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Brain: Tumours
	house id	1
	identifier	213360
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	07/11/2014 13:57:04
	question text	To ask the Secretary of State for Health, with reference to NHS England's Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review published in November 2014, what evidence NHS England has received that demonstrates that instances of both malignant and benign brain tumours are lower in England than in other devoloped countries; and for what reasons NHS England is supporting proposals which will prevent the NHS from adopting a programme to allow it to reach parity with other developed countries for the provision of stereotactic radiotherapy for brain tumours.
	session	2014/15
	session number	4
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	title	House of Commons Tabled Parliamentary Question 2014/15 213360
	type	WrittenParliamentaryQuestion
	uin	213360
	version	1
	written parliamentary question type	NamedDay
	answer	answer
	creator	4089 label Biography information for Tessa Munt
	publisher	25259 pref label House of Commons
	tabling member	4089 label Biography information for Tessa Munt

106321

	human indexable
	published
	registered interest
	answer date	07/11/2014
	date	04/11/2014
	date tabled	04/11/2014
	ddp created	04/11/2014 22:20:37
	ddp modified	08/02/2015 06:43:27
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiotherapy
	house id	1
	identifier	213361
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	07/11/2014 13:57:04
	question text	To ask the Secretary of State for Health, with reference to NHS England's Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review published in November 2014, section 58, how NHS England is able accurately to protect the growth requirements for stereotactic radiosurgery if the data source it is using does not allow it to draw firm conclusions for the purposes of this Review.
	session	2014/15
	session number	4
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	title	House of Commons Tabled Parliamentary Question 2014/15 213361
	type	WrittenParliamentaryQuestion
	uin	213361
	version	1
	written parliamentary question type	NamedDay
	answer	answer
	creator	4089 label Biography information for Tessa Munt
	publisher	25259 pref label House of Commons
	tabling member	4089 label Biography information for Tessa Munt